United States of America proposing to reclassify non-invasive bone growth stimulators, postamendments class III device Food and Drug Administration (FDA), Health and Human Services (HHS) is proposing to reclassify non-invasive bone growth stimulators, postamendments class III devices (product codes LOF and LPQ), into class II (special controls), subject to premarket notification. FDA is also proposing a new device classification with the name "non-invasive bone growth stimulators" along with the proposed special controls that the Agency believes are necessary to provide a reasonable assurance of safety and effectiveness of these devices. FDA is proposing this reclassification on its own initiative. If finalized, this order will reclassify these devices from class III (premarket approval) to class II (special controls) and reduce the regulatory burdens associated with these devices, as these devices will no longer be required to submit a premarket approval application (PMA), but are subject to premarket notification (510(k)) requirements and general and special controls. Products covered : Non-invasive bone growth stimulators; Medical equipment (ICS 11.040) HS Code: 8528 Proposed date of adoption:To be determined Proposed date of entry into force:To be determined Final date for comments:16 October 2020 | 
.gif)
